Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention.

Harskamp RE, Beijk MA, Damman P, Tijssen JG, Lopes RD, de Winter RJ.

Am J Cardiol. 2013 Jan 15;111(2):153-8. doi: 10.1016/j.amjcard.2012.09.010. Epub 2012 Oct 24.

PMID:
23102882
2.

Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.

Ramana RK, Ronan A, Cohoon K, Homan D, Sutherland J, Steen L, Liu J, Loeb H, Lewis BE.

Catheter Cardiovasc Interv. 2008 Jun 1;71(7):886-93. doi: 10.1002/ccd.21552.

PMID:
18412238
3.

The effect of total arterial grafting on medium-term outcomes following coronary artery bypass grafting.

Légaré JF, Hassan A, Buth KJ, Sullivan JA.

J Cardiothorac Surg. 2007 Oct 23;2:44.

4.

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y, et al.

Circulation. 1989 Nov;80(5):1190-7.

PMID:
2680158
5.

Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.

Gasparovic H, Petricevic M, Kopjar T, Djuric Z, Svetina L, Biocina B.

Am J Cardiol. 2014 May 15;113(10):1660-7. doi: 10.1016/j.amjcard.2014.02.024. Epub 2014 Mar 1.

6.

Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.

Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S.

J Am Coll Cardiol. 2010 Nov 9;56(20):1639-43. doi: 10.1016/j.jacc.2010.03.104.

7.

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.

Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y, et al.

Circulation. 1988 Jun;77(6):1324-32.

PMID:
3286040
8.

Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.

Brodie BR, VerSteeg DS, Brodie MM, Hansen C, Richter SJ, Stuckey TD, Gupta N, Pulsipher M, Downey W.

Catheter Cardiovasc Interv. 2005 Aug;65(4):504-9.

PMID:
15988742
9.

Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.

Gaglia MA Jr, Torguson R, Xue Z, Gonzalez MA, Ben-Dor I, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.

Catheter Cardiovasc Interv. 2011 Jul 1;78(1):23-9. doi: 10.1002/ccd.22873. Epub 2011 Mar 16.

PMID:
21061247
10.

Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.

Mehta RH, Honeycutt E, Peterson ED, Granger CB, Halabi AR, Shaw LK, Smith PK, Califf RM, Harrington RA, Sketch MH Jr.

Circulation. 2006 Jul 4;114(1 Suppl):I396-401.

11.
12.

Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.

Monaco M, Di Tommaso L, Pinna GB, Lillo S, Schiavone V, Stassano P.

J Vasc Surg. 2012 Jul;56(1):96-105. doi: 10.1016/j.jvs.2012.01.004. Epub 2012 May 1.

13.

Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.

Rajah SM, Nair U, Rees M, Saunders N, Walker D, Williams G, Critchley A, Beton D, Campbell C, Lawson RA, et al.

J Thorac Cardiovasc Surg. 1994 Apr;107(4):1146-53.

PMID:
8159037
14.

Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).

Lee MS, Hu PP, Aragon J, Shah AP, Oyama J, Dhoot J, Iqbal Z, Jones N, Penny W, Tobis J, Mahmud E, French W.

Am J Cardiol. 2010 Aug 1;106(3):337-41. doi: 10.1016/j.amjcard.2010.03.030.

PMID:
20643242
15.

Discontinuation of long-term clopidogrel therapy is associated with death and myocardial infarction after saphenous vein graft percutaneous coronary intervention.

Sachdeva A, Bavisetty S, Beckham G, Shen AY, Aharonian V, Mansukhani P, Stone GW, Leon M, Moses J, Moore N, Hyett R, Contreras R, Brar SS.

J Am Coll Cardiol. 2012 Dec 11;60(23):2357-63. doi: 10.1016/j.jacc.2012.09.014. Epub 2012 Nov 7.

16.

[Efficacy and outcome of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction due to saphenous vein graft occlusion].

Ergelen M, Uyarel H, Gül M, Türer A, Yıldırım E, Bozbay M, Demirci D, Ersan D, Türkkan C, Uluganyan M, Tezel T.

Turk Kardiyol Dern Ars. 2010 Dec;38(8):531-6. Turkish.

17.

Arterial grafting results in reduced operative mortality and enhanced long-term quality of life in octogenarians.

Kurlansky PA, Williams DB, Traad EA, Carrillo RG, Schor JS, Zucker M, Singer S, Ebra G.

Ann Thorac Surg. 2003 Aug;76(2):418-26; discussion 427.

PMID:
12902077
18.

Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.

Gluckman TJ, McLean RC, Schulman SP, Kickler TS, Shapiro EP, Conte JV, McNicholas KW, Segal JB, Rade JJ.

J Am Coll Cardiol. 2011 Mar 1;57(9):1069-77. doi: 10.1016/j.jacc.2010.08.650.

19.

Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.

Nocerino AG, Achenbach S, Taylor AJ.

Am J Cardiol. 2013 Nov 15;112(10):1576-9. doi: 10.1016/j.amjcard.2013.07.017. Epub 2013 Sep 13. Review.

PMID:
24035160
20.

Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.

Kulik A, Le May MR, Voisine P, Tardif JC, Delarochelliere R, Naidoo S, Wells GA, Mesana TG, Ruel M.

Circulation. 2010 Dec 21;122(25):2680-7. doi: 10.1161/CIRCULATIONAHA.110.978007. Epub 2010 Dec 6.

Supplemental Content

Support Center